A biopharmaceutical company collaborating with Hawai'i scientists on an Ebola vaccine announced encouraging news about its vaccine today.
Jul 19, 2016
0
1
Though the West African Ebola outbreak that began in 2013 is now under control, 23 countries remain environmentally suitable for animal-to-human transmission of the Ebola virus. Only seven of these countries have experienced ...
Jul 14, 2016
1
0
The Partnership for Research on Ebola Virus in Liberia (PREVAIL), a U.S.-Liberia joint Clinical Research Partnership, today announced the opening of PREVAIL IV, a treatment trial for men who have survived Ebola virus disease ...
Jul 5, 2016
0
0
A first-of-its-kind Ebola study yields clues to how some people are able to survive the deadly virus and suggests possible avenues for treatments that could save more lives.
Jun 30, 2016
0
0
Sexual transmission of the Ebola virus could have a major impact on the dynamics of the disease, potentially reigniting an outbreak that has been contained by public health interventions, according to research by University ...
Jun 7, 2016
0
106
To be prepared for new Ebola virus disease cases, it is fundamental to start by identifying the range of the virus and the regions that are more favorable for its propagation. A team from the Center of International Forestry ...
Jun 7, 2016
0
0
Serious health and safety concerns for health care, public safety and support service personnel arose after the 2014 Ebola virus disease that resulted in 11,000 deaths across multiple countries, with four confirmed cases ...
Jun 1, 2016
0
2
(HealthDay)—Infection control measures have been developed to strengthen hospitals' capacity for safely diagnosing and treating patients with Ebola virus disease (EVD), according to a review published online May 10 in the ...
May 13, 2016
0
1
Ebola virus samples taken from patients in Liberia in June 2015 are strikingly similar in their genetic makeup to other Ebola virus sequences from Western Africa, according to research published online today in the journal ...
Apr 29, 2016
0
51
In a study appearing in the April 19, 2016 issue of JAMA, Matthew D. Snape, F.R.C.P.C.H., M.D., of the University of Oxford, United Kingdom, and colleagues conducted a phase 1 trial to evaluate the tolerability and immunogenicity ...
Apr 19, 2016
0
4
